Intraoperative Monitoring of the Pelvic Autonomic Nerves
NCT ID: NCT01585727
Last Updated: 2019-02-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
188 participants
INTERVENTIONAL
2012-06-30
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study will examine the impact of a newly developed continuous monitoring device for preservation of urogenital function in patients with TME for rectal cancer. 188 patients will be included in the prospective, randomized, single-blind, parallel group multi-centre trial including two arms (TME with and without intraoperative continuous monitoring of pelvic autonomic nerves). The primary efficacy endpoint is the change in urinary function measured by International Prostate Function Score (IPSS) 12 months after surgery. Genital functions measured as secondary endpoints. The application of the continuous intraoperative neuromonitoring device could enhance the objective intraoperative confirmation of pelvic nerve sparing surgery. The investigators hypothesis is that the use of his device minimizes the risk of postoperative urogenital dysfunction in patients with TME for rectal cancer. An enormous reduction of treatment costs is to be expected.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Urinary and Sexual Dysfunctions Evaluation After Rectal Resection
NCT04404673
Lateral Pelvic Lymph Node Dissection for Rectal Neuroendocrine Neoplasms Undergoing Laparoscopic Total Mesenteric Excision
NCT06279299
Multicenter Study on Laparoscopic Versus Open PANP-TME for Male Mid-low Rectal Cancer Patients
NCT02165800
Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer
NCT00910143
Endoscopic Posterior Mesorectal Resection in T1 Rectal Cancer
NCT00531297
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TME with neuromonitoring
Total mesorectal excision with intraoperative neuromonitoring of pelvic autonomic nerves.
TME
Total mesorectal excision
Neuromonitoring
Intraoperative neuromonitoring of pelvic autonomic nerves.
TME without neuromontoring
Total mesorectal excision without intraoperative neuromonitoring of pelvic autonomic nerves.
TME
Total mesorectal excision
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TME
Total mesorectal excision
TME
Total mesorectal excision
Neuromonitoring
Intraoperative neuromonitoring of pelvic autonomic nerves.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* histologically confirmed carcinoma of the rectum (≤ 16 cm from anal verge)
* fit for radical surgery
* total mesorectal excision
* age 18-80 years
Exclusion Criteria
* pacemaker
* emergency operation
* multivisceral resection in the pelvis
* partial mesorectal excision
* eligibility for local excision (TEM, intestinal wall resection)
* ongoing infection or sepsis
* severe untreated physical or mental impairment
* pregnancy or breastfeeding
* women of childbearing potential who are not using a highly effective birth control method
* missing preoperative data on urogenital or anorectal function
* simultaneous participation in another clinical trial
* previous participation in this clinical trial
* lack of cooperation with the trial procedure
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johannes Gutenberg University Mainz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Werner Kneist
Senior physician, Department of Visceral and Abdominal Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Werner Kneist, Univ.-Prof.
Role: PRINCIPAL_INVESTIGATOR
Department of Visceral and Abdominal Surgery, University Medical Center Mainz
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of General and Visceral Surgery, University Medical Center Mainz
Mainz, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kauff DW, Kronfeld K, Gorbulev S, Wachtlin D, Lang H, Kneist W. Continuous intraoperative monitoring of pelvic autonomic nerves during TME to prevent urogenital and anorectal dysfunction in rectal cancer patients (NEUROS): a randomized controlled trial. BMC Cancer. 2016 May 21;16:323. doi: 10.1186/s12885-016-2348-4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-012
Identifier Type: -
Identifier Source: org_study_id
KN 930/1-1
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.